Stocks Comparison
Edwards Lifesciences vs Zimmer Biomet: revenue, profit, margins and growth compared
Edwards Lifesciences brought in $6.1B of revenue in fiscal 2025, Zimmer Biomet $8.2B in fiscal 2025. Revenue changed by +11.5% at Edwards Lifesciences and +7.2% at Zimmer Biomet on the year before, so Edwards Lifesciences grew faster. Edwards Lifesciences kept 17.7% of its revenue as net profit, Zimmer Biomet 8.6%. Free cash flow was $1.3B at Edwards Lifesciences and $1.5B at Zimmer Biomet.
Side by side, latest fiscal year
| EW | ZBH | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $6.1B | $8.2B |
| Revenue growth | +11.5% | +7.2% |
| Net income | $1.1B | $705.1M |
| Net margin | 17.7% | 8.6% |
| Free cash flow | $1.3B | $1.5B |
| Free cash flow margin | 22.0% | 17.9% |
| Earnings per share (diluted) | $1.83 | $3.55 |
| Cash | $2.9B | $591.9M |
| Debt | $598.3M | $7.5B |
| Price to earnings | 47.1 | 25.6 |
| Market value | $49.7B | $17.4B |
| Dividend yield | n/a | 1.05% |
| Rank by revenue in sector | #54 of 523 · Health care | #51 of 523 · Health care |
Over the years
Questions about Edwards Lifesciences and Zimmer Biomet
Which is bigger by revenue, Edwards Lifesciences or Zimmer Biomet?
Zimmer Biomet is bigger by revenue: $8.2B in fiscal 2025, against $6.1B for Edwards Lifesciences in fiscal 2025.
Which keeps more of its revenue as profit, Edwards Lifesciences or Zimmer Biomet?
Edwards Lifesciences had a net margin of 17.7% in fiscal 2025; Zimmer Biomet had 8.6% in fiscal 2025.
Which grew revenue faster, Edwards Lifesciences or Zimmer Biomet?
In their latest fiscal years revenue changed by +11.5% at Edwards Lifesciences and +7.2% at Zimmer Biomet.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.